Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1852 1
1856 1
1873 1
1879 1
1896 1
1898 1
1901 2
1905 1
1906 1
1907 2
1908 2
1910 3
1911 4
1912 5
1913 6
1914 5
1915 4
1916 5
1917 3
1918 2
1919 4
1921 1
1922 2
1923 8
1924 5
1925 3
1926 4
1927 8
1928 5
1929 3
1930 2
1931 8
1932 7
1933 4
1934 6
1935 6
1936 6
1937 5
1938 10
1939 12
1940 11
1941 6
1942 6
1943 1
1944 7
1945 54
1946 198
1947 299
1948 283
1949 310
1950 463
1951 700
1952 814
1953 910
1954 969
1955 1093
1956 1118
1957 1153
1958 1107
1959 1203
1960 1345
1961 1602
1962 1823
1963 2701
1964 3614
1965 2800
1966 2939
1967 3714
1968 4291
1969 4767
1970 5265
1971 5991
1972 6673
1973 7443
1974 8068
1975 9133
1976 9091
1977 9479
1978 10095
1979 11134
1980 11941
1981 12690
1982 13543
1983 15306
1984 16840
1985 17918
1986 18546
1987 19233
1988 20456
1989 23524
1990 24670
1991 24907
1992 26869
1993 28124
1994 30357
1995 31089
1996 32577
1997 33995
1998 35045
1999 36652
2000 38899
2001 40986
2002 42565
2003 45683
2004 49610
2005 52812
2006 55639
2007 58931
2008 61725
2009 65387
2010 71201
2011 77213
2012 82906
2013 87408
2014 91659
2015 96065
2016 95309
2017 97664
2018 101537
2019 107936
2020 116421
2021 120127
2022 113894
2023 106635
2024 40826

Text availability

Article attribute

Article type

Publication date

Search Results

2,305,295 results

Results by year

Filters applied: . Clear all
The following terms were not found in PubMed: Hirsutism+Cushingoid, features+Secondary, Amenorrhea+Stromal
Page 1
Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.
Liao CP, Booker RC, Brosseau JP, Chen Z, Mo J, Tchegnon E, Wang Y, Clapp DW, Le LQ. Liao CP, et al. J Clin Invest. 2018 Jul 2;128(7):2848-2861. doi: 10.1172/JCI99424. Epub 2018 May 21. J Clin Invest. 2018. PMID: 29596064 Free PMC article.
Neurofibromatosis type 1 associates with multiple neoplasms, and the Schwann cell tumor neurofibroma is the most prevalent. ...In the present study, we use new, genetically engineered Scf mice to decipher the contributions of tumor-derived SCF a …
Neurofibromatosis type 1 associates with multiple neoplasms, and the Schwann cell tumor neurofibroma is the most …
Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
Mo J, Anastasaki C, Chen Z, Shipman T, Papke J, Yin K, Gutmann DH, Le LQ. Mo J, et al. J Clin Invest. 2021 Jan 4;131(1):e139807. doi: 10.1172/JCI139807. J Clin Invest. 2021. PMID: 33108355 Free PMC article.
Neurofibromatosis type 1 (NF1) is a common tumor predisposition syndrome caused by NF1 gene mutation, in which affected patients develop Schwann cell lineage peripheral nerve sheath tumors (neurofibromas). ...To confirm that SOX10+ SLCs contained the …
Neurofibromatosis type 1 (NF1) is a common tumor predisposition syndrome caused by NF1 gene mutation, in which affected patients deve …
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.
Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, Reilly KM, Stemmer-Rachamimov A, Stewart DR, Viskochil D, Widemann B, Perry A. Miettinen MM, et al. Hum Pathol. 2017 Sep;67:1-10. doi: 10.1016/j.humpath.2017.05.010. Epub 2017 May 24. Hum Pathol. 2017. PMID: 28551330 Free PMC article. Review.
Patients with neurofibromatosis 1 (NF1) develop multiple neurofibromas, with 8% to 15% of patients experiencing malignant peripheral nerve sheath tumor (MPNST) during their lifetime. ...Although neurofibromas contain numerous S100 protein/SOX10-positive Schwa …
Patients with neurofibromatosis 1 (NF1) develop multiple neurofibromas, with 8% to 15% of patients experiencing malignant peripheral …
Benign Neurogenic Tumors.
Farma JM, Porpiglia AS, Vo ET. Farma JM, et al. Surg Clin North Am. 2022 Aug;102(4):679-693. doi: 10.1016/j.suc.2022.04.007. Surg Clin North Am. 2022. PMID: 35952696 Review.
Neurogenic tumors arise from cells of the nervous system. These tumors can be found anywhere along the distribution of the sympathetic and parasympathetic nervous system and are categorized based on cell of origin: ganglion cell, paraganglion …
Neurogenic tumors arise from cells of the nervous system. These tumors can be found anywhere along the distribution of …
Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.
Anastasaki C, Mo J, Chen JK, Chatterjee J, Pan Y, Scheaffer SM, Cobb O, Monje M, Le LQ, Gutmann DH. Anastasaki C, et al. Nat Commun. 2022 May 19;13(1):2785. doi: 10.1038/s41467-022-30466-6. Nat Commun. 2022. PMID: 35589737 Free PMC article.
We discovered a neurofibroma mitogen (COL1A2) produced by peripheral neurons in an activity-regulated manner, which increases NF1-deficient Schwann cell proliferation, establishing that neurofibromas are regulated by neuronal activity. In contrast, mice with …
We discovered a neurofibroma mitogen (COL1A2) produced by peripheral neurons in an activity-regulated manner, which increases NF1-def …
What's new in nerve sheath tumors.
Meyer A, Billings SD. Meyer A, et al. Virchows Arch. 2020 Jan;476(1):65-80. doi: 10.1007/s00428-019-02671-0. Epub 2019 Nov 9. Virchows Arch. 2020. PMID: 31707590 Review.
Peripheral nerve sheath tumors are commonly encountered and frequently pose challenges to the pathologist and the clinician. ...
Peripheral nerve sheath tumors are commonly encountered and frequently pose challenges to the pathologist and the clinician. ...
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.
Kershner LJ, Choi K, Wu J, Zhang X, Perrino M, Salomonis N, Shern JF, Ratner N. Kershner LJ, et al. JCI Insight. 2022 Sep 22;7(18):e154513. doi: 10.1172/jci.insight.154513. JCI Insight. 2022. PMID: 36134665 Free PMC article.
Affected individuals develop neurofibromas, benign tumors driven by NF1 loss in Schwann cells (SCs). By comparing normal nerve cells to plexiform neurofibroma (PN) cells using single-cell and bulk RNA sequencing, we identified chan …
Affected individuals develop neurofibromas, benign tumors driven by NF1 loss in Schwann cells (SCs). By comparing norma …
Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with Nf1 Knockout in Boundary Cap Cells.
Radomska KJ, Coulpier F, Gresset A, Schmitt A, Debbiche A, Lemoine S, Wolkenstein P, Vallat JM, Charnay P, Topilko P. Radomska KJ, et al. Cancer Discov. 2019 Jan;9(1):130-147. doi: 10.1158/2159-8290.CD-18-0156. Epub 2018 Oct 22. Cancer Discov. 2019. PMID: 30348676 Free article.
Patients carrying an inactive NF1 allele develop tumors of Schwann cell origin called neurofibromas (NF). Genetically engineered mouse models have significantly enriched our understanding of plexiform forms of NFs (pNF). However, this has not been the case fo …
Patients carrying an inactive NF1 allele develop tumors of Schwann cell origin called neurofibromas (NF). Genetically e …
Postauricular Masses.
Tasli H, Gokgoz MC, Karakoc O. Tasli H, et al. J Craniofac Surg. 2020 Sep;31(6):e555-e560. doi: 10.1097/SCS.0000000000006526. J Craniofac Surg. 2020. PMID: 32604279
Of the neoplastic masses, 6 (11.5%) were nonmelanoma skin cancer, comprising 4 (7.6%) basal cell carcinomas and 2 (3.8%) squamous cell carcinomas. A total of 9 (17.3%) neoplastic masses were benign, comprising 3 (5.7%) lipomas, 3 (5.7%) temporal bone osteomas, 2 (3. …
Of the neoplastic masses, 6 (11.5%) were nonmelanoma skin cancer, comprising 4 (7.6%) basal cell carcinomas and 2 (3.8%) squamous …
Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.
Jiang C, McKay RM, Lee SY, Romo CG, Blakeley JO, Haniffa M, Serra E, Steensma MR, Largaespada D, Le LQ. Jiang C, et al. J Invest Dermatol. 2023 Aug;143(8):1369-1377. doi: 10.1016/j.jid.2022.12.027. Epub 2023 Jun 15. J Invest Dermatol. 2023. PMID: 37318402 Review.
Neurofibromatosis type 1 is one of the most common genetic disorders of the nervous system and predisposes patients to develop benign and malignant tumors. Cutaneous neurofibromas (cNFs) are NF1-associated benign tumors that affect nearly 100% of patients wit …
Neurofibromatosis type 1 is one of the most common genetic disorders of the nervous system and predisposes patients to develop benign and ma …
2,305,295 results
You have reached the last available page of results. Please see the User Guide for more information.